Ferrous Fumarate 200mg Tablets
Natural health product licensed in Canada
- Other names
- Dr Nutrition 360 Ferrous Fumarate 200mg Tablets, Ferrous Fumarate, Life Ferrous Fumarate 200mg Tablets, Life Ferrous fumarate, MapleLife Nutrition Ferrous Fumarate 200mg Tablets
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80091364
- Status
- Active licence
- Licence date
- 19 March 2019
- Revision date
- 6 September 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hydrogénophosphate de calcium dihydraté, Crospovidone, Stéarate de magnésium, Talc, Dioxyde de silicium, Cellulose microcristalline, Amidon de maïs, Poly(alcool vinylique), Hypromellose, Poly(dextrose), Laque d'aluminium FD&C Rouge n° 40, Poly(éthylène glycol), Carboxyméthylcellulose de sodium, Anhydrous Dibasic Calcium Phosphate, Povidone, Laque d'aluminium bleu FD&C n° 1, Croscarmellose de sodium, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency. Helps to prevent iron deficiency anaemia. Helps to prevent iron deficiency anemia and associated tiredness and fatigue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience constipation, diarrhoea and/or vomiting. Hypersensitivity has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80091364
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging